Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine Physicians

Pulmonary Embolism Clinical Trial

— Observ-MTEV  

Official title:

Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine Physicians

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04272723
• Other study ID #: PI2020_843_0014
• Status: Completed
• Start date: August 21, 2019
• Est. completion date: July 1, 2023

Study information

• Verified date: July 2023
• Source: Centre Hospitalier Universitaire, Amiens
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

In France, venous thromboembolic (VTE) disease is usually managed by vascular medicine physicians (VMP). The national OPTIMEV study, conducted more than 12 years ago among VMP practicing in hospital and in the community described the management of VTE in routine clinical practice. Since then a large number of practice changing studies have been published. This includes trials that have validated the use of direct oral anticoagulants (DOAC), the new standard of care of VTE, as per new national and international guidelines. Management of VTE in 2019 appears to be significantly different from the one that prevailed more than 10 years ago when the last national survey was conducted. It is therefore important to have an update on the routine clinical practice management of VTE by VMP. In this perspective the investigators aim to conduct a national survey among VMP practicing in France

Recruitment information / eligibility

• Status: Completed
• Enrollment: 383
• Est. completion date: July 1, 2023
• Est. primary completion date: July 1, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• vascular medicine physicians who are active members of the SFMV (French Society of Vascular Medicine)

• vascular medicine physicians registered as willing to do medical research

Exclusion Criteria:

• vascular medicine physicians who refuse to provide consent

• vascular medicine physicians who are retired

• non-practicing vascular medicine physicians

Related Conditions & MeSH terms

• Anticoagulant
• Deep Vein Thrombosis
• Embolism
• Pulmonary Embolism
• Survey
• Thromboembolism
• Thrombosis
• Venous Thromboembolism
• Venous Thrombosis

Locations

Country	Name	City	State
France	CHU Amiens	Amiens

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire, Amiens

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Inter-practician variability of clinical care of venous thromboembolic in routine clinical practice	The variation in venous thromboembolic management in routine clinical practice is assessed by analysing the management of the 5 consecutive acute venous thromboembolic patients reported by each participating physician	up to 3 months after inclusion
Secondary	Inter-practician variability of clinical care of venous thromboembolic according to patient age	patient characteristics are : cancer, extreme body weight, severe renal impairment, elderly or pregnant patients, high bleeding risk	up to 6 months after inclusion
Secondary	Inter-practician variability of clinical care of venous thromboembolic according to patient body weight	patient characteristics are : cancer, extreme body weight, severe renal impairment, elderly or pregnant patients, high bleeding risk	up to 6 months after inclusion
Secondary	Inter-practician variability of clinical care of venous thromboembolic according to patient bleeding risk	patient characteristics are : cancer, extreme body weight, severe renal impairment, elderly or pregnant patients, high bleeding risk	up to 6 months after inclusion